The last few years have shown a major change in first-line management of restless legs. In this podcast, Dr. Michael Silber discusses why gabapentinoids are now first-line therapy rather than dopamine agonists, how they are used, and whether there is any role still for the dopaminergic drugs.
Version: 20241125
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.